Why We Built Grantverse | The 12-Layer Capital Intelligence Platform

According to Carta's 2025 Founder Ownership Report, the median startup founding team retains just 23% of their company by Series B.

Not because they built something small. Not because they failed. Because every founder they surveyed followed the same playbook: need money, give away equity, repeat until you're a minority shareholder in your own company.

But here's what most founders never hear: there are eleven other capital sources you can and should tap before ever giving away a single share. R&D tax credits. Grants. Government loans. Competitions. Corporate credits. Program-related investments. Green financing. Revenue-based financing. Invoice financing. Venture debt. Government procurement. Layer those before equity and you can keep 30% or more of what you built.

That's not a theory. That's what we saw happen across 500+ startups and $30 million in secured funding over three years of hands-on consulting work.

Grantverse is a 12-layer capital intelligence platform that maps all twelve capital sources into one AI-optimized funding plan, so founders can raise smarter, earlier, and keep more of what's theirs. It includes a free Capital Readiness Score, AI-drafted grant applications, and outcome tracking that measures real win rates and funding secured. And equally important, it bridges the gap between startups and investors by giving investors an outcome-verified window into which founders have already secured non-dilutive funding, won grants, and proven they can compete for capital without giving up equity.

Here's how we got here.

It Started with a Backpack and a Resignation Letter

In 2021, I quit my comfortable 9-to-5. I had 10 years of grant writing experience, a backpack, and the kind of post-pandemic clarity that makes you question everything about how you've been spending your time.

I didn't leave with a plan to start a company. I left to travel. Mexico City. Tbilisi. Kuala Lumpur. Small towns between bigger ones. No pitch decks, no investor meetings. Just movement.

What I found along the way changed everything.

In every city, in every community, I met people doing extraordinary work with almost nothing. Activists running education programs out of borrowed rooms. Small entrepreneurs building products that solved real problems for their neighbors. Community leaders with 10-year visions and 10-week budgets.

They all had the same problem. They knew what they wanted to build, but they had no idea how to fund it. And when they did try to find funding, they defaulted to the only paths they knew: personal savings, credit cards, loans from family, or debt that could bury them before they ever got traction.

Nobody had told them about grants. Nobody had shown them what non-dilutive capital even looked like. They didn't know there was a way to fund their work without giving away ownership or going into debt.

I had spent a decade writing grants. I knew how to navigate that world. And for the first time, I realized that expertise wasn't just a job skill. It was something people desperately needed.

That's when it started.

Grant Nomad: 500 Startups, $30M, and a Pattern We Couldn't Ignore

I founded Grant Nomad in 2022 with zero savings, zero clients, and what I'll politely call a dangerous level of optimism.

Three years later, Grant Nomad has become one of the fastest-growing boutique grant writing companies in the world. We've helped secure over $30 million in grant funding for more than 500 clients, 71% of them for-profit companies in sectors like medtech, biotech, AI, sustainability, and education.

The breakdown tells a story about where the money actually is:

$14 million (47%) from private foundations
$11 million (36%) from government and federal programs
$5 million (17%) from state and regional grants
Clients and wins spanning the US, Europe, Australia, Canada, Africa, and Southeast Asia

In November 2025, I was invited to speak at MedTech World Malta, one of the largest MedTech summits in the world, with over 2,000 global attendees, to discuss how non-dilutive funding can help founders retain full ownership while accelerating growth.

But the more founders we worked with, the more a painful pattern emerged. And it had less to do with grants and more to do with a fundamental misunderstanding of how startups should be funded in the first place.

The Problems We Kept Seeing

Founders Were Destroying Their Own Cap Tables

Every week, a new founder would sit across from us with the same story. They needed capital. They didn't know where to find it. So they did what everyone around them was doing: they pitched VCs and gave away equity. Or worse, they took on personal debt, maxed out credit cards, borrowed from friends and family, or signed loan agreements with terms that would haunt them for years.

The data confirms how common this is. Based on SCORE survey data, 78% of startups don't seek outside financing at all in their first year. Instead, they rely on personal savings (66.3%) or income from another job (27.6%). The Kauffman Foundation found that 83% of new businesses with employees don't access capital from banks or financial institutions. And according to Embroker's analysis, only 0.05% of startups obtain venture capital.

So what happens to everyone else? They bootstrap on fumes, take on toxic debt, or give away massive chunks of equity at the worst possible moment, when their company is at its lowest valuation and they have the least leverage.

The cost is staggering. Based on Carta's analysis of 45,000+ startups, the median founding team gives up roughly 20% of equity at seed, another 20% at Series A, and 17% at Series B. By the time they reach Series B, founders collectively own just 23% of the company they created. By Series D, that number drops to 10.3%.

According to PitchBook's 2023 Annual US VC Valuations Report, pre-seed startups gave up roughly 25% of equity in their very first round. A quarter of the company gone before there's a product in the market.

And the compounding math is what really kills you. Carta calculated that the difference between 2019 and 2024 median dilution rates, compounded from seed through Series D, equals a 7.6 percentage point gap in retained ownership. At a $1 billion valuation, that gap is worth $76 million. Every unnecessary point you give away early doesn't just shrink your slice. It shrinks the value of every future negotiation you'll ever have.

Most Founders Had No Idea Non-Dilutive Capital Even Existed

This is the part that kept us up at night.

We weren't just meeting founders who had made bad funding decisions. We were meeting smart, capable people who simply didn't know there was another option. The entire concept of non-dilutive capital, funding that doesn't require giving up shares, was invisible to them.

Grants? They thought those were only for nonprofits. R&D tax credits? Their accountant had never mentioned it. Competitions? They'd heard of a few but never applied. Revenue-based financing? Venture debt? Program-related investments? Blank stares.

The data confirms how widespread this gap is. Approximately 70% of eligible startups do not claim the R&D tax credit, largely because they wrongly believe R&D only applies to lab-based work. Meanwhile, the U.S. federal government distributes $4.7 billion per year in grants specifically designed for small businesses through the SBIR and STTR programs.

On the foundation side, the picture is even more striking. U.S. foundations distributed over $103 billion in grants in 2023. But grants to non-501(c)(3) organizations, the category that includes for-profit startups, totaled roughly $34 million. That's 0.03% of the total. For-profit companies doing social impact work in healthcare, education, and sustainability are effectively locked out of over $100 billion in annual giving. Not by law. By habit.

The money is there. Billions of dollars, every year, earmarked for exactly the kind of work these startups are doing. But the founders who need it most don't know it exists.

The Insight That Changed Everything

After three years and 500+ engagements at Grant Nomad, one pattern was impossible to miss: when you layer non-dilutive funding before equity, founders keep dramatically more ownership. And when investors can see that a founder has already secured non-dilutive capital, it changes the entire dynamic of the relationship.

Here's a simplified example based on what we saw repeatedly. Take a typical biotech startup that needs $2 million to reach its next milestone.

Path A, the default: The founder raises a $2M seed round at a $6M pre-money valuation. They give up 25% of the company immediately. If they later raise a Series A and Series B at median dilution rates, they're down to roughly 23% ownership by Series B.

Path B, what we teach: The founder secures a $250K SBIR Phase I grant, wins a $100K competition, claims $50K in R&D tax credits, and gets $200K in revenue-based financing. That's $600K in non-dilutive capital that extends the runway by 8 to 12 months. Now the equity raise is smaller ($1.4M instead of $2M), the valuation is higher, and the dilution is significantly lower. By Series B, this founder retains 30 to 35% instead of 23%.

We call this the broken capital stack problem. And the fix isn't a better pitch deck or a warmer intro to a VC. The fix is a fundamentally different approach to how startups plan, sequence, and communicate their capital.

From Consulting to Platform: Why We Built Grantverse

Grant Nomad works. But it can't scale.

One consulting team, no matter how experienced, can only serve so many founders at once. But the problems we solve are not small roster problems. Hundreds of thousands of startups need this, and most of them can't afford boutique consulting fees or don't even know they should be looking for this kind of help.

What finally pushed us to build was realizing that the same playbook repeated across every single engagement: Research what grants and non-dilutive sources the company qualifies for. Score their readiness to compete. Map all twelve capital sources into a sequenced plan. Model the dilution impact of different funding scenarios. Track deadlines, applications, and compliance. And then connect that founder with investors who value financial discipline.

That's not consulting. That's a product.

Here's what Grantverse does, in plain language.

It is a 12-layer capital intelligence platform that maps all twelve capital sources into one AI-optimized funding plan, so founders can raise smarter, earlier, and keep more of what's theirs.

Every startup that uses Grantverse gets:

Free Capital Readiness Score (0-100, A-F) — a benchmarked assessment of how prepared they are to compete for and win non-dilutive funding.
290+ verified grant opportunities and 68 tax credit programs — with eligibility filtering, deadline tracking, and AI-drafted application sections.
Outcome tracking — that records grant wins, losses, and award amounts to measure real results over time.
Monte Carlo dilution modeling — 5,000-scenario simulations that show exactly what different funding strategies cost in ownership.
A full 12-layer capital plan — that sequences all twelve layers in the right order for their specific stage, sector, and goals.

For investors, Grantverse creates an outcome-verified, transparent profile for every startup that shows grant wins, applications submitted, non-dilutive funding secured, win rates, and the overall capital strategy.

What We're Building Next

Grantverse is currently in beta, and we're opening access in waves.

The vision is straightforward. Grant Nomad stays as the premium managed service for founders who want senior-led, hands-on support. Grantverse becomes the self-serve platform that makes capital strategy accessible to every startup, at every stage, regardless of whether they can afford a consulting engagement.

Same expertise. Same playbook. Delivered as software instead of services.

If you're a founder who wants to stop giving away equity before you have to, or an investor who wants to back founders with proven financial discipline, we'd like to hear from you.

Grants Are Infrastructure, Not Charity

I'll close with something I said at MedTech World Malta, because I believe it more today than when I first said it:

"Innovation in healthcare shouldn't rely on luck, and grants should not be seen as just good old charity. They are the infrastructure that sustains good science long enough to reach those who need it most."

That's true for healthcare. It's also true for climate tech, education, AI, and any field where startups are building things that matter.

There is a better way to fund a startup. We built Grant Nomad to prove it one founder at a time. We built Grantverse to scale it to every founder, everywhere.

Your equity is not the first thing you should give away. It should be the last.